• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Barry J Iacopetta
  • Biology, Medicine
  • Human mutation
  • 2003 (First Publication: 1 March 2003)
  • Approximately half of all colorectal cancers show p53 (TP53) gene mutations, with higher frequencies observed in distal colon and rectal tumors and lower frequencies in proximal tumors and those withExpand
  • Barry J Iacopetta
  • Medicine
  • International journal of cancer
  • 2002 (First Publication: 10 October 2002)
  • Colorectal carcinomas (CRC) that arise proximal (right) or distal (left) to the splenic flexure exhibit differences in incidence according to geographic region, age and gender. Together withExpand
  • Antonio Russo, Viviana Bazan, Barry J Iacopetta, David Kerr, Thierry Soussi, Nicola Gebbia
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2005 (First Publication: 20 October 2005)
  • PURPOSE The aims of the TP53 Colorectal Cancer (CRC) International Collaborative Study were to evaluate the possible associations between specific TP53 mutations and tumor site, and to evaluate theExpand
  • Wendy K. Glenn, Benjamin Heng, Warick J Delprado, Barry J Iacopetta, Noel James Whitaker, James S Lawson
  • Medicine, Biology
  • PloS one
  • 2012 (First Publication: 19 November 2012)
  • Background The purpose of this investigation is to determine if Epstein Barr virus (EBV), high risk human papillomavirus (HPV), and mouse mammary tumour viruses (MMTV) co-exist in some breastExpand
  • Hany Elsaleh, Brenda J. Powell, +4 authors Barry J Iacopetta
  • Biology, Medicine
  • Clinical cancer research : an official journal of…
  • 2001
  • PURPOSE We recently presented evidence for tumor site and gender-specificity in the survival benefit from adjuvant chemotherapy in Stage III colorectal cancer (CRC). In the current study, we examinedExpand